Bioxel Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 1

Bioxel General Information

Description

Developer of therapies using peptides and proteins designed to improve treatment effectiveness and precision. The company is currently operating in stealth mode.

Contact Information

Website
bioxel.net
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • One Kendall Square
  • Suite B-4401
  • Cambridge, MA 02139
  • United States
Primary Industry
Decision/Risk Analysis
Other Industries
Biotechnology
Drug Discovery
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • One Kendall Square
  • Suite B-4401
  • Cambridge, MA 02139
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Bioxel Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC Completed Stealth
To view Bioxel’s complete valuation and funding history, request access »

Bioxel Patents

  • 6

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 5

    Pending

  • Expiring in next 12 mo

Bioxel Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20250345398-A1 Agents and methods for treating disease Pending 19-Mar-2024
EP-4620486-A1 Conjugates of g-protein coupled receptor agonists and antagonists Inactive 19-Mar-2024
US-20250269042-A1 Multifunctional proteolysis-targeting chimera conjugates and uses in treating neurological diseases Pending 27-Feb-2024
US-20250144189-A1 Asparagine racemase and uses thereof Pending 06-Nov-2023
US-20250213706-A1 Multifunctional proteolysis-targeting chimera conjugates Pending 17-Oct-2023 A61P35/00
To view Bioxel’s complete patent history, request access »

Bioxel Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Biological Engineering Ventures Venture Capital Minority
To view Bioxel’s complete investors history, request access »

Ready to get started?

Request a free trial

Bioxel FAQs

  • When was Bioxel founded?

    Bioxel was founded in 2023.

  • Where is Bioxel headquartered?

    Bioxel is headquartered in Cambridge, MA.

  • What industry is Bioxel in?

    Bioxel’s primary industry is Decision/Risk Analysis.

  • Is Bioxel a private or public company?

    Bioxel is a Private company.

  • What is Bioxel’s current revenue?

    The current revenue for Bioxel is .

  • Who are Bioxel’s investors?

    Biological Engineering Ventures has invested in Bioxel.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process